Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Calcitonin gene-related peptide (CGRP) receptor antagonists: pyridine as a replacement for a core amide groupGuanglin Luo, Ling Chen, Rita Civiello, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2014
Serendipitous oxidation product of BIBN4096BS: a potent CGRP receptor antagonistBireshwar Dasgupta, Edward Kozlowski, Daniel R Schroeder, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2016
Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidinesRita L Civiello, Xiaojun Han, Brett R Beno, et al.
The New England Journal of Medicine|July 11, 2019
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for MigraineRichard B Lipton, Robert Croop, Elyse G Stock, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
Doxorubicin immunoconjugates containing bivalent, lysosomally-cleavable dipeptide linkagesGene M Dubowchik, Shilpa Radia, Harold Mastalerz, et al.
Organic Letters|June 4, 2005
Stereoselective synthesis of new conformationally restricted analogues of a potent CGRP receptor antagonistDmitry Zuev, Jodi A Michne, Hong Huang, et al.
Bioorganic & Medicinal Chemistry Letters|July 2, 2005
Synthesis, structure-activity relationships, and anxiolytic activity of 7-aryl-6,7-dihydroimidazoimidazole corticotropin-releasing factor 1 receptor antagonistsXiaojun Han, Jodi A Michne, Sokhom S Pin, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2013
Preparation of imidazoles as potent calcitonin gene-related peptide (CGRP) antagonistsGeorge Tora, Andrew P Degnan, Charles M Conway, et al.
Bioorganic & Medicinal Chemistry Letters|January 20, 2023
Structure-activity relationship (SAR) studies on substituted N-(pyridin-3-yl)-2-amino-isonicotinamides as highly potent and selective glycogen synthase kinase-3 (GSK-3) inhibitorsGuanglin Luo, Ling Chen, Swanee Jacutin-Porte, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2007
An orally active corticotropin releasing factor 1 receptor antagonist from 8-aryl-1,3a,7,8-tetraaza-cyclopenta[a]indenesXiaojun Han, Rita Civiello, Sokhom S Pin, et al.
Pageof 5